BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

21062

544067

INNOVACAP

img img img img
No Data Available

INNOVA CAPTAB LIMITED performance

Today’s low

Today’s high

₹ 716.00 ₹ 750.70
₹ 724.90

52 week low

52 week high

₹ 660.00 ₹ 1260.00
₹ 724.90

Open Price

₹ 733.00

Prev. Close

₹ 739.60

Volume (Shares)

10757.00

Total traded value

₹ 77.97

Upper Circuit

₹ 887.50

Lower Circuit

₹ 591.70

info

INNOVA CAPTAB LIMITED Share Price Update

As of the latest trading session, INNOVA CAPTAB LIMITED share price is currently at ₹ 724.9, which is down by ₹ -14.69 from its previous closing. Today, the stock has fluctuated between ₹ 716.00 and ₹ 750.70. Over the past year, INNOVA CAPTAB LIMITED has achieved a return of -32.08 %. In the last month alone, the return has been -0.11 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

INNOVA CAPTAB LIMITED fundamentals


  • Market cap (Cr)

    4,148.20

  • P/E Ratio (TTM)

    55.60

  • Beta

    1.34

  • Book Value / share

    148.30

  • Return on equity

    11.64%

  • EPS (TTM)

    13.31

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    14.33

info icon alternate text
  • Market cap (Cr)

    4,155.40

  • P/E Ratio (TTM)

    55.60

  • Beta

    1.23

  • Book Value / share

    148.30

  • Return on equity

    11.64%

  • EPS (TTM)

    13.31

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    14.33

info icon alternate text

INNOVA CAPTAB LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 289.83
Operating Expense 275.20
Net Profit 14.33
Net Profit Margin (%) 4.94
Earnings Per Share (EPS) 2.50
EBITDA 33.96
Effective Tax Rate (%) 25.63
Particulars JUN 2025 (Values in Cr)
Revenue 286.98
Operating Expense 264.00
Net Profit 20.30
Net Profit Margin (%) 7.07
Earnings Per Share (EPS) 3.55
EBITDA 39.14
Effective Tax Rate (%) 25.65
Particulars MAR 2025 (Values in Cr)
Revenue 242.52
Operating Expense 224.02
Net Profit 17.13
Net Profit Margin (%) 7.06
Earnings Per Share (EPS) 2.99
EBITDA 32.54
Effective Tax Rate (%) 25.06
Particulars DEC 2024 (Values in Cr)
Revenue 248.53
Operating Expense 219.24
Net Profit 24.40
Net Profit Margin (%) 9.81
Earnings Per Share (EPS) 4.26
EBITDA 35.98
Effective Tax Rate (%) 25.54
Particulars SEP 2024 (Values in Cr)
Revenue 240.18
Operating Expense 210.15
Net Profit 25.61
Net Profit Margin (%) 10.66
Earnings Per Share (EPS) 4.48
EBITDA 37.47
Effective Tax Rate (%) 25.37
Particulars MAR 2025 (Values in Cr)
Revenue 958.06
Operating Expense 854.94
Net Profit 89.47
Net Profit Margin (%) 9.33
Earnings Per Share (EPS) 15.63
EBITDA 139.08
Effective Tax Rate (%) 25.37
Particulars MAR 2024 (Values in Cr)
Revenue 864.93
Operating Expense 781.95
Net Profit 68.16
Net Profit Margin (%) 7.88
Earnings Per Share (EPS) 13.48
EBITDA 118.69
Effective Tax Rate (%) 27.25
Particulars MAR 2023 (Values in Cr)
Revenue 858.67
Operating Expense 789.09
Net Profit 57.55
Net Profit Margin (%) 6.70
Earnings Per Share (EPS) 11.99
EBITDA 107.27
Effective Tax Rate (%) 26.51
Particulars MAR 2022 (Values in Cr)
Revenue 785.46
Operating Expense 699.68
Net Profit 66.18
Net Profit Margin (%) 8.42
Earnings Per Share (EPS) 550.05
EBITDA 101.36
Effective Tax Rate (%) 25.34
Particulars MAR 2021 (Values in Cr)
Revenue 410.66
Operating Expense 365.69
Net Profit 34.50
Net Profit Margin (%) 8.40
Earnings Per Share (EPS) 286.85
EBITDA 55.87
Effective Tax Rate (%) 25.55
Particulars MAR 2025 (Values in Cr)
Book Value / Share 167.66
ROE % 14.33
ROCE % 14.50
Total Debt to Total Equity 0.33
EBITDA Margin 15.94
Particulars MAR 2024 (Values in Cr)
Book Value / Share 145.20
ROE % 17.04
ROCE % 18.76
Total Debt to Total Equity 0.38
EBITDA Margin 15.44
Particulars MAR 2023 (Values in Cr)
Book Value / Share 57.61
ROE % 28.01
ROCE % 23.92
Total Debt to Total Equity 0.73
EBITDA Margin 13.26
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1738.38
ROE % 36.19
ROCE % 30.38
Total Debt to Total Equity 0.69
EBITDA Margin 12.35
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1206.84
ROE % 27.04
ROCE % 28.18
Total Debt to Total Equity 0.39
EBITDA Margin 13.60
Particulars MAR 2025 (Values in Cr)
Book Value / Share 142.06
ROE % 11.64
ROCE % 11.53
Total Debt to Total Equity 0.37
EBITDA Margin 14.52
Particulars MAR 2024 (Values in Cr)
Book Value / Share 126.47
ROE % 13.74
ROCE % 14.44
Total Debt to Total Equity 0.42
EBITDA Margin 13.72
Particulars MAR 2023 (Values in Cr)
Book Value / Share 55.90
ROE % 24.02
ROCE % 21.34
Total Debt to Total Equity 0.70
EBITDA Margin 12.49
Particulars MAR 2022 (Values in Cr)
Book Value / Share 175.69
ROE % 37.22
ROCE % 32.34
Total Debt to Total Equity 0.62
EBITDA Margin 12.91
Particulars MAR 2021 (Values in Cr)
Book Value / Share 1206.84
ROE % 27.04
ROCE % 28.18
Total Debt to Total Equity 0.39
EBITDA Margin 13.60
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 68.16
Total Assets 1580.40
Total Liabilities 1580.40
Total Equity 959.41
Share Outstanding 57224929
Price to Book Ratio 6.18
Return on Assets (%) 8.11
Return on Capital (%) 9.9
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 86.74
Total Assets 1320.88
Total Liabilities 1320.88
Total Equity 830.89
Share Outstanding 57224929
Price to Book Ratio 3.54
Return on Assets (%) 7.14
Return on Capital (%) 8.8
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 18.87
Total Assets 704.41
Total Liabilities 704.41
Total Equity 276.50
Share Outstanding 48000000
Price to Book Ratio 0.00
Return on Assets (%) 9.64
Return on Capital (%) 13.28
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.43
Total Assets 575.47
Total Liabilities 575.47
Total Equity 208.60
Share Outstanding 1200000
Price to Book Ratio 0.00
Return on Assets (%) 11.11
Return on Capital (%) 15.72
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.89
Total Assets 369.61
Total Liabilities 369.61
Total Equity 144.82
Share Outstanding 1200000
Price to Book Ratio 0.00
Return on Assets (%) 9.33
Return on Capital (%) 18.17
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 67.89
Total Assets 1365.14
Total Liabilities 1365.14
Total Equity 812.96
Share Outstanding 57224929
Price to Book Ratio 6.18
Return on Assets (%) 6.55
Return on Capital (%) 7.85
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 86.35
Total Assets 1155.06
Total Liabilities 1155.06
Total Equity 723.71
Share Outstanding 57224929
Price to Book Ratio 3.54
Return on Assets (%) 5.90
Return on Capital (%) 7.07
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 14.98
Total Assets 678.33
Total Liabilities 678.33
Total Equity 268.32
Share Outstanding 48000000
Price to Book Ratio 0.00
Return on Assets (%) 8.48
Return on Capital (%) 11.43
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.18
Total Assets 544.91
Total Liabilities 544.91
Total Equity 210.82
Share Outstanding 12000000
Price to Book Ratio 0.00
Return on Assets (%) 12.14
Return on Capital (%) 17.11
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.89
Total Assets 369.61
Total Liabilities 369.61
Total Equity 144.82
Share Outstanding 1200000
Price to Book Ratio 0.00
Return on Assets (%) 9.33
Return on Capital (%) 18.17
Particulars MAR 2025 (Values in Cr)
Net Income 171.01
Cash from Operations 87.55
Cash from Investing -151.58
Cash from Financing 91.53
Net change in Cash 3.79
Free Cash Flow 260.05
Particulars MAR 2024 (Values in Cr)
Net Income 129.52
Cash from Operations 173.99
Cash from Investing -498.97
Cash from Financing 360.83
Net change in Cash 8.20
Free Cash Flow 461.35
Particulars MAR 2023 (Values in Cr)
Net Income 91.79
Cash from Operations 86.65
Cash from Investing -90.84
Cash from Financing 27.09
Net change in Cash 3.37
Free Cash Flow 165.64
Particulars MAR 2022 (Values in Cr)
Net Income 85.72
Cash from Operations 79.74
Cash from Investing -188.11
Cash from Financing 124.57
Net change in Cash -4.64
Free Cash Flow 159.62
Particulars MAR 2021 (Values in Cr)
Net Income 46.34
Cash from Operations 54.79
Cash from Investing -19.67
Cash from Financing -19.33
Net change in Cash 2.55
Free Cash Flow 73.53
Particulars MAR 2025 (Values in Cr)
Net Income 119.89
Cash from Operations 39.19
Cash from Investing -99.74
Cash from Financing 83.86
Net change in Cash 3.91
Free Cash Flow 200.12
Particulars MAR 2024 (Values in Cr)
Net Income 93.69
Cash from Operations 135.66
Cash from Investing -471.55
Cash from Financing 368.13
Net change in Cash 8.25
Free Cash Flow 412.89
Particulars MAR 2023 (Values in Cr)
Net Income 78.30
Cash from Operations 58.18
Cash from Investing -87.53
Cash from Financing 51.28
Net change in Cash 3.03
Free Cash Flow 137.07
Particulars MAR 2022 (Values in Cr)
Net Income 88.63
Cash from Operations 79.25
Cash from Investing -188.33
Cash from Financing 125.29
Net change in Cash -4.69
Free Cash Flow 159.12
Particulars MAR 2021 (Values in Cr)
Net Income 46.34
Cash from Operations 54.94
Cash from Investing -19.67
Cash from Financing -19.33
Net change in Cash 2.56
Free Cash Flow 73.68
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.86 13.17 1.39 205.84 25.97 / 68.00
BLISS GVS PHARMA LTD 150.45 14.52 1.40 1591.60 105.05 / 190.65
CIPLA LTD 1489.15 22.11 3.65 120289.25 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 300.55 7.90 2.26 884.55 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 26.86 21.84 3.74 205.84 25.97 / 68.00
AMRUTAJAN HEALTH LTD 651.80 33.24 5.50 1884.39 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9014.05 97.48 28.20 22535.13 6301.00 / 10653.05
BLISS GVS PHARMA LTD 150.45 20.30 1.44 1591.60 105.05 / 190.65

INNOVA CAPTAB LIMITED shareholding pattern

Holding

28.85%
50.89%
0.07%
20.16%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

INNOVA CAPTAB LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
724.90 -1.98 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 718.30
  • 26 Days 738.00
  • 10 Days 718.10
  • 50 Days 769.20
  • 12 Days 719.70
  • 100 Days 808.70
  • 20 Days 729.50
  • 200 Days 826.20
721.02 PIVOT

First Support

665.13

First Resistance

782.03

Second Support

604.12

Second Resistance

837.92

Third Support

548.23

Third Resistance

898.93

RSI

46.80

ADX

26.29

MACD

-21.80

Williams % R

-43.41

Commodity Channel Index (CCI)

-15.55

Date

2025-12-10

Week

17189.00

Same Day

11230.00

Month

16714.00

1 Year

1.35

3 Year

0.94

Over 1 Month

-0.11%

down

Over 1 Year

-32.08%

down

Over 3 Months

-15.27%

down

Over 3 Years

0.00%

down

Over 6 Months

-14.51%

down

Over 5 Years

0.00%

down

INNOVA CAPTAB LIMITED Corporate Actions

INNOVA CAPTAB LIMITED Share Price

Innova Captab Limited was incorporated as Harun Health Care Private Limited', dated January 3, 2005, as a Private Limited Company at Mumbai. Thereafter, the name of the Company was changed from Harun Health Care Private Limited' to Innova Captab Private Limited', and a fresh Certificate of Incorporation dated February 2, 2010, was issued by RoC to the Company. Subsequently, Company got converted to a Public Company on July 12, 2018, and the name was changed to Innova Captab Limited', dated July 26, 2018.

The Company is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports. Their business includes contract development and manufacturing organization (CDMO) business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business.

Their CDMO product portfolio spans across both acute and chronic therapeutic areas. These CDMO services and products include commercial large-scale manufacturing of generic products, which allow customers in offering multiple dosage forms, including oral solids, oral liquids, dry syrups and injectables, modified and release forms of tablets in capsules. It has 2 manufacturing facilities in Baddi, Himachal Pradesh. Their facilities further produce tablets, capsules, dry syrups, dry powder injections, ointments and liquid orals.

In 2006, the first manufacturing plant got established in Baddi, at Himachal Pradesh.

In 2010, it commenced operations at the cephalosporin block of their plant in Baddi.

In 2021, the Company acquired business of Innova Captab, a Partnership Firm, as a going concern through Slump Sale effective in March, 2021 and acquired Univentis Medicare Limited (UML) 100% equity shares effective on December 31, 2021 and consequently, The Univentis Foundation became a Subsidiary of Company on June 14, 2021.

The Company commenced construction to establish an industrial plant in Jammu and Kashmir and to build an R&D center in Panchkula, Haryana in 2022.

In December 2023, the Company came up with an IPO aggregating to Rs 570 Crores by issuing 12,723,214 Equity Shares, comprising 7,142,857 Equity Shares aggregating to Rs 320 Crore through Fresh Issue and 5,580,357 Equity Shares aggregating to Rs 250 Crore through Offer for Sale.

The Company acquired Sharon Bio-Medicine Limited in June, 2023. In 2024-25, Company commissioned a new greenfield facility in Kathua, Jammu w.e.f. 14 January, 2025.

Parent organization Indian Private
NSE symbol INNOVACAP
Founded 2005
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Innova Captab Ltd?

Answer Field

Innova Captab Ltd share price is for NSE ₹ 724.90 & for BSE ₹ 726.15 as on Dec 11 2025 03:30 PM.

What is the Market Cap of Innova Captab Ltd Share?

Answer Field

The market cap of Innova Captab Ltd for NSE ₹ 4,148.23 & for BSE ₹ 4,155.38 as on Dec 11 2025 03:30 PM.

What is the 52 Week High and Low of Innova Captab Ltd?

Answer Field

The 52 Week High and Low of Innova Captab Ltd for NSE is ₹ 1,260.00 and ₹ 660.00 and for BSE is ₹ 1,259.00 and ₹ 655.15.

What is 1 year return for Innova Captab Ltd?

Answer Field

The 1 year returns on the stock has been -32.08%.

What is the P/E Ratio of Innova Captab Ltd Share?

Answer Field

As on Dec 11 2025 03:30 PM the price-to-earnings (PE) ratio for Innova Captab Ltd share is 55.60.

What is the PB ratio of Innova Captab Ltd Share?

Answer Field

As on Dec 11 2025 03:30 PM, the price-to-book (PB) ratio for Innova Captab Ltd share is 148.30.

How to Buy Innova Captab Ltd Share?

Answer Field

You can trade in Innova Captab Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Innova Captab Ltd Share on Bajaj Broking App?

Answer Field

To buy Innova Captab Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Innova Captab Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59